Gongwin Biopharm Holdings Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported net loss was TWD 89.21 million compared to TWD 58.46 million a year ago. Basic loss per share from continuing operations was TWD 0.81 compared to TWD 0.53 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
181.5 TWD | -0.82% | -1.36% | -1.63% |
1st Jan change | Capi. | |
---|---|---|
-1.63% | 631M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 6617 Stock
- News Gongwin Biopharm Holdings Co., Ltd.
- Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022